Min Cheng1, Xiangfeng Lu, Jianfeng Huang, Shu Zhang, Dongfeng Gu. 1. State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Abstract
BACKGROUND: Electrocardiographic PR interval prolongation is considered a benign condition, but recent studies have challenged the notion by demonstrating that prolonged PR interval is associated with an increased risk of atrial fibrillation (AF). OBJECTIVE: The purpose of this study was to perform a meta-analysis of prospective cohort studies to evaluate the evidence supporting an association of prolonged PR interval with AF incidence. METHODS: We searched the MEDLINE and EMBASE database (from inception to May 2014) supplemented by manual searches of references of relevant retrieved articles. Prospective cohort studies were included with hazard ratio (HR) of prolonged PR interval for incident AF. RESULTS: The search strategy yielded 6 cohort studies meeting eligibility criteria. A total of 328,932 participants were included, with 14,191 participants suffering from AF during follow-up. Pooled HRs of prolonged PR interval for incident AF was 1.30 (95% CI: 1.13 to 1.49) using random-effect model (I(2) = 30%). There was a significant difference of combined HRs between studies with and without adjustment for taking of AV nodal blocking agents in subgroup analysis. Sensitivity analysis supported the robustness of the results. CONCLUSIONS: Prolonged PR interval is not a totally benign condition but an independent risk factor for AF incidence. The mechanisms underlying the association of prolonged PR interval with AF incidence need further research.
BACKGROUND: Electrocardiographic PR interval prolongation is considered a benign condition, but recent studies have challenged the notion by demonstrating that prolonged PR interval is associated with an increased risk of atrial fibrillation (AF). OBJECTIVE: The purpose of this study was to perform a meta-analysis of prospective cohort studies to evaluate the evidence supporting an association of prolonged PR interval with AF incidence. METHODS: We searched the MEDLINE and EMBASE database (from inception to May 2014) supplemented by manual searches of references of relevant retrieved articles. Prospective cohort studies were included with hazard ratio (HR) of prolonged PR interval for incident AF. RESULTS: The search strategy yielded 6 cohort studies meeting eligibility criteria. A total of 328,932 participants were included, with 14,191 participants suffering from AF during follow-up. Pooled HRs of prolonged PR interval for incident AF was 1.30 (95% CI: 1.13 to 1.49) using random-effect model (I(2) = 30%). There was a significant difference of combined HRs between studies with and without adjustment for taking of AV nodal blocking agents in subgroup analysis. Sensitivity analysis supported the robustness of the results. CONCLUSIONS: Prolonged PR interval is not a totally benign condition but an independent risk factor for AF incidence. The mechanisms underlying the association of prolonged PR interval with AF incidence need further research.
Authors: Mariam B Seifert; Morten S Olesen; Ingrid E Christophersen; Jonas B Nielsen; Jonas Carlson; Fredrik Holmqvist; Arnljot Tveit; Stig Haunsø; Jesper H Svendsen; Pyotr G Platonov Journal: Ann Noninvasive Electrocardiol Date: 2019-06-01 Impact factor: 1.468
Authors: Jens Cosedis Nielsen; Yenn-Jiang Lin; Marcio Jansen de Oliveira Figueiredo; Alireza Sepehri Shamloo; Alberto Alfie; Serge Boveda; Nikolaos Dagres; Dario Di Toro; Lee L Eckhardt; Kenneth Ellenbogen; Carina Hardy; Takanori Ikeda; Aparna Jaswal; Elizabeth Kaufman; Andrew Krahn; Kengo Kusano; Valentina Kutyifa; Han S Lim; Gregory Y H Lip; Santiago Nava-Townsend; Hui-Nam Pak; Gerardo Rodríguez Diez; William Sauer; Anil Saxena; Jesper Hastrup Svendsen; Diego Vanegas; Marmar Vaseghi; Arthur Wilde; T Jared Bunch; Alfred E Buxton; Gonzalo Calvimontes; Tze-Fan Chao; Lars Eckardt; Heidi Estner; Anne M Gillis; Rodrigo Isa; Josef Kautzner; Philippe Maury; Joshua D Moss; Gi-Byung Nam; Brian Olshansky; Luis Fernando Pava Molano; Mauricio Pimentel; Mukund Prabhu; Wendy S Tzou; Philipp Sommer; Janice Swampillai; Alejandro Vidal; Thomas Deneke; Gerhard Hindricks; Christophe Leclercq Journal: Europace Date: 2020-08-01 Impact factor: 5.214
Authors: Jonathan D Mosley; M Benjamin Shoemaker; Quinn S Wells; Dawood Darbar; Christian M Shaffer; Todd L Edwards; Lisa Bastarache; Catherine A McCarty; Will Thompson; Christopher G Chute; Gail P Jarvik; David R Crosslin; Eric B Larson; Iftikhar J Kullo; Jennifer A Pacheco; Peggy L Peissig; Murray H Brilliant; James G Linneman; John S Witte; Josh C Denny; Dan M Roden Journal: Circ Cardiovasc Genet Date: 2017-04
Authors: Kwang Jin Chun; Jin Kyung Hwang; So Ra Choi; Seung-Jung Park; Young Keun On; June Soo Kim; Kyoung-Min Park Journal: J Korean Med Sci Date: 2016-02-22 Impact factor: 2.153
Authors: Claudia T Silva; Irina V Zorkoltseva; Najaf Amin; Ayşe Demirkan; Elisabeth M van Leeuwen; Jan A Kors; Marten van den Berg; Bruno H Stricker; André G Uitterlinden; Anatoly V Kirichenko; Jacqueline C M Witteman; Rob Willemsen; Ben A Oostra; Tatiana I Axenovich; Cornelia M van Duijn; Aaron Isaacs Journal: Front Genet Date: 2016-11-08 Impact factor: 4.599
Authors: Theodora Nikolaidou; Pierpaolo Pellicori; Jufen Zhang; Syed Kazmi; Kevin M Goode; John G Cleland; Andrew L Clark Journal: Clin Res Cardiol Date: 2017-09-15 Impact factor: 5.460
Authors: Faisal Rahman; Na Wang; Xiaoyan Yin; Patrick T Ellinor; Steven A Lubitz; Paul A LeLorier; David D McManus; Lisa M Sullivan; Sudha Seshadri; Ramachandran S Vasan; Emelia J Benjamin; Jared W Magnani Journal: Heart Rhythm Date: 2015-07-28 Impact factor: 6.343
Authors: Alexander J Kula; Ronit Katz; Leila R Zelnick; Elsayed Soliman; Alan Go; Michael Shlipak; Rajat Deo; Bonnie Ky; Ian DeBoer; Amanda Anderson; Rob Christenson; Stephen L Seliger; Chris Defilippi; Harold I Feldman; Myles Wolf; John Kusek; Tariq Shafi; Jiang He; Nisha Bansal Journal: Nephrol Dial Transplant Date: 2021-12-02 Impact factor: 5.992